Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213711-14-000005

Chairman of the Board acquired 6,060,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TREPPEL JERRY Chairman of the Board 2014-09-10 Conversion +6,060,000 9,266,558 D
Derivatives
TREPPEL JERRY Chairman of the Board 2014-09-10 Conversion · Series I Convertible Preferred Shares −4.24 $100,000.00 $424,200 0 D
Loading xslF345X03/primary_doc.xml…